Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials
Authors:
- 5 August 2015
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 35 (5) , 1253-1261
Abstract
The objective of this study was to evaluate the efficacy and safety of topical diclofenac therapy for osteoarthritis (OA). A meta-analysis of randomized controlled trials was conducted. A comprehensive literature search, covering the databases of Medline, the Cochrane Central Register of Controlled Trials, and EMBASE, was conducted in September 2014 to identify the randomized controlled trials which adopted the topical diclofenac therapy for OA. A total of nine papers were included in this meta-analysis. Topical diclofenac appears to be effective in both pain relief (standard mean differences (SMD) = 0.40; 95 % confidence interval (CI) 0.19 to 0.62; P = 0.0003) and function improvement (SMD = 0.23; 95 % CI 0.03 to 0.43; P = 0.03) when compared with the control group. The sensitivity analysis and subgroup analysis showed that the result of pain intensity was stable and reliable, while the result of physical function improvement was vague. With respect to safety, topical diclofenac demonstrated a higher incidence of adverse events such as dry skin, rash, dermatitis, neck pain, and withdrawal. Topical diclofenac is effective in pain relief as a treatment of OA. It may also have a potential effect in function improvement, which needs further studies to be explored. Although, some adverse effects were observed in the application of topical diclofenac, none of them was serious.Keywords
This publication has 41 references indexed in Scilit:
- Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Knee Osteoarthritis: A Randomized Controlled TrialThe Physician and Sportsmedicine, 2010
- Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled TrialThe Journal of Rheumatology, 2009
- Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritisPain, 2009
- A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patientsBMC Musculoskeletal Disorders, 2008
- Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I StudyThe American Journal of Medicine, 2006
- Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trialCanadian Medical Association Journal, 2004
- Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health careAnnals of the Rheumatic Diseases, 2001
- Oral versus Topical NSAIDs in Rheumatic DiseasesDrugs, 2000
- Diclofenac metabolic profile followingin vitro percutaneous absorption through viable human skinEuropean Journal of Drug Metabolism and Pharmacokinetics, 1999
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999